WES-based association study of cefaclor-induced anaphylaxis
This dataset contains exome-aligned BAM and BAI files from patients with cefaclor-induced anaphylaxis. Exome sequencing was performed using the Illumina NovaSeq6000 platform with GRCh37 as the reference genome.
- 74 samples
- DAC: EGAC50000000691
- Technology: Illumina NovaSeq 6000
DUO:0000021 version: 2021-02-23
ethics approval required
This data use modifier indicates that the requestor must provide documentation of local IRB/ERB approval.
DUO:0000027 version: 2021-02-23
project specific restriction
This data use modifier indicates that use is limited to use within an approved project.
DUO:0000043 version: 2021-02-23
clinical care use
This data use modifier indicates that use is allowed for clinical use and care.
Controlled access for cefaclor-induced anaphylaxis WES dataset
Participants provided informed consent for the use of their genomic and clinical data in pharmacogenomic and biomedical research. Data may be shared with qualified researchers under controlled access conditions and may not be used for commercial purposes. Reuse is restricted to non-profit academic use, and data must not be used for re-identification of participants.
